In this work, we show that tumour-intrinsic KEAP1/NRF2 mutations and subsequent pathway activation can be non-invasively imaged by [18F]FSPG PET imaging in a variety of animal models of NSCLC. The gene discussed is NFE2L2; the disease is neoplasm.